FTX-6746

Modify Date: 2026-08-06 15:07:26

FTX-6746 Structure
FTX-6746 structure
Common Name FTX-6746
CAS Number 2829349-96-2 Molecular Weight 316.69
Density N/A Boiling Point N/A
Molecular Formula C16H7ClF2N2O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of FTX-6746


FTX-6746 is an orally active PPARG inhibitor. FTX-6746 shows potent tumor inhibition in mouse xenograft models[1].

 Names

Name FTX-6746

 FTX-6746 Biological Activity

Description FTX-6746 is an orally active PPARG inhibitor. FTX-6746 shows potent tumor inhibition in mouse xenograft models[1].
Related Catalog
Target

PPARγ

In Vivo FTX-6746 (3-60 mg/kg;口服;每天 2 次,共 21 天) 在小鼠的 UMUC9 或 HT1197 异种移植模型中有显着的肿瘤抑制作用[1]。 Animal Model: UMUC9 or HT1197 xenograft model in NCG or Balb/C nude mice[1] Dosage: 3 mg/kg, 10 mg/kg, 30 mg/kg, 60 mg/kg Administration: PO; twice daily for 21 days Result: Resulted >100% tumor growth inhibition at day 21 in HT1197 xenograft model. Resulted up to 80% target gene suppression in tumor tissue at day 2.
References

[1]. Mertz J, et al. Novel inhibitors of the luminal lineage transcription factor peroxisome proliferator-activated receptor gamma (PPARG) durably eradicate tumors in urothelial cancer (UC) animal models[J]. European Journal of Cancer, 2022, 174: S33-S34.

 Chemical & Physical Properties

Molecular Formula C16H7ClF2N2O
Molecular Weight 316.69
InChIKey PCCCYEBARWZCEY-UHFFFAOYSA-N
SMILES N#Cc1ccc(Cl)c(-c2cc(=O)c3c(F)cc(F)cc3[nH]2)c1
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.